Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant SATB2 anticorps (AA 200-300)

Cet anticorps Lapin Monoclonal détecte spécifiquement SATB2 dans IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN7126418

Aperçu rapide pour Recombinant SATB2 anticorps (AA 200-300) (ABIN7126418)

Antigène

Voir toutes SATB2 Anticorps
SATB2 (SATB Homeobox 2 (SATB2))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 63
  • 35
  • 30
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 55
  • 8
Lapin

Clonalité

  • 42
  • 21
Monoclonal

Conjugué

  • 33
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SATB2 est non-conjugé

Application

  • 44
  • 20
  • 15
  • 13
  • 13
  • 13
  • 8
  • 7
  • 6
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Épitope

    • 16
    • 8
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 200-300

    Specificité

    SATB2 is a DNA binding protein that specifically binds nuclear matrix attachment regions. It is involved in transcription regulation and chromatin remodeling. SATB2 expression in colorectal carcinomas (CRC) is correlated with good prognosis and in laryngeal squamous cell carcinoma it functions as a tumor suppressor wherein loss of expression is positively correlated with high tumor grade and recurrence. Moreover, SATB2, in combination with CK20, could identify almost all CRC s. Upper gastrointestinal (GI) carcinomas and pancreatic ductal carcinomas are usually negative for SATB2, and ovarian carcinomas, lung adenocarcinomas, and adenocarcinomas from other origin are rarely positive for SATB2. Additionally, SATB2 antibody can identify neuroendocrine neoplasms of colon and rectum because SATB2 is usually negative in neuroendocrine neoplasms of the GI tract, pancreas, and lung. More recently, it has been reported that SATB2 is a sensitive marker for tumors with osteoblastic differentiation.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Synthetic peptide corresponding to residues within aa200-300 corresponding to human SATB2

    Isotype

    IgG
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human colon or cerebral cortex tissue.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    SATB2 (SATB Homeobox 2 (SATB2))

    Autre désignation

    SATB2

    Sujet

    DNA-binding protein SATB2, GLSS, SATB homeobox 2, Special AT-rich sequence-binding protein 2,SATB2 (Colorectal Carcinoma Marker)
    Cellular localisation: Nuclear

    Poids moléculaire

    83kDa

    ID gène

    23314, 516617

    UniProt

    Q9UPW6
Vous êtes ici:
Chat with us!